[Loratadine in the treatment of seasonal allergic rhinitis]. 1994

Z Buko, and Z Siergiejko, and S Chyrek-Borowska
Oddziału Otolaryngologii Wojewódzkiego Szpitala Zespolonego w Białymstoku.

A single blind, placebo-controlled, parallel-group study was performed during a pollen season in 41 patients suffering from seasonal allergic rhinitis. A group of 26 patients was treated with loratadine (10 mg daily in one dose) for 3 weeks. Placebo was given in the group of 15 patients (1 tablet daily) during 8-10 days. The following parameters were assessed: clinical symptoms (rhinorhea, sneezing, blockage, nasal itching, eye symptoms), rhinoscopy, at baseline and after 8 and 21 days of the treatment. Eosinophils in nasal secretion were countered before and after the medication. Patients recorded daily nasal and ocular symptoms and possible adverse events in diary cards. It was shown a statistical significant improvement of clinical symptoms in the group treated with loratadine in comparison with the placebo group (p < 0.01). Very good and good results were observed in 84.6% of the treated with loratadine patients. The reduction of eosinophilia in nasal secretion during medication period was noted. Loratadine did not induce more side effects than placebo.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004804 Eosinophils Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin. Eosinophil
D005260 Female Females
D006255 Rhinitis, Allergic, Seasonal Allergic rhinitis that occurs at the same time every year. It is characterized by acute CONJUNCTIVITIS with lacrimation and ITCHING, and regarded as an allergic condition triggered by specific ALLERGENS. Hay Fever,Pollen Allergy,Pollinosis,Seasonal Allergic Rhinitis,Hayfever,Allergic Rhinitides, Seasonal,Allergic Rhinitis, Seasonal,Allergies, Pollen,Allergy, Pollen,Fever, Hay,Pollen Allergies,Pollinoses,Rhinitides, Seasonal Allergic,Rhinitis, Seasonal Allergic,Seasonal Allergic Rhinitides
D006634 Histamine H1 Antagonists Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. Antihistamines, Classical,Antihistaminics, Classical,Antihistaminics, H1,Histamine H1 Antagonist,Histamine H1 Receptor Antagonist,Histamine H1 Receptor Antagonists,Histamine H1 Receptor Blockaders,Antagonists, Histamine H1,Antagonists, Histamine H1 Receptor,Antihistamines, Sedating,Blockaders, Histamine H1 Receptor,First Generation H1 Antagonists,H1 Receptor Blockaders,Histamine H1 Blockers,Receptor Blockaders, H1,Antagonist, Histamine H1,Classical Antihistamines,Classical Antihistaminics,H1 Antagonist, Histamine,H1 Antagonists, Histamine,H1 Antihistaminics,Sedating Antihistamines
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016037 Single-Blind Method A method in which either the observer(s) or the subject(s) is kept ignorant of the group to which the subjects are assigned. Single-Masked Study,Single-Blind Study,Single-Masked Method,Method, Single-Blind,Method, Single-Masked,Methods, Single-Blind,Methods, Single-Masked,Single Blind Method,Single Blind Study,Single Masked Method,Single Masked Study,Single-Blind Methods,Single-Blind Studies,Single-Masked Methods,Single-Masked Studies,Studies, Single-Blind,Studies, Single-Masked,Study, Single-Blind,Study, Single-Masked

Related Publications

Z Buko, and Z Siergiejko, and S Chyrek-Borowska
December 1990, Asian Pacific journal of allergy and immunology,
Z Buko, and Z Siergiejko, and S Chyrek-Borowska
September 1994, Annals of allergy,
Z Buko, and Z Siergiejko, and S Chyrek-Borowska
January 2008, Allergy and asthma proceedings,
Z Buko, and Z Siergiejko, and S Chyrek-Borowska
September 1992, Allergie et immunologie,
Z Buko, and Z Siergiejko, and S Chyrek-Borowska
February 1996, The Journal of allergy and clinical immunology,
Z Buko, and Z Siergiejko, and S Chyrek-Borowska
January 1988, Zeitschrift fur Hautkrankheiten,
Z Buko, and Z Siergiejko, and S Chyrek-Borowska
October 1989, Annals of allergy,
Z Buko, and Z Siergiejko, and S Chyrek-Borowska
January 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
Z Buko, and Z Siergiejko, and S Chyrek-Borowska
July 1997, The American journal of managed care,
Z Buko, and Z Siergiejko, and S Chyrek-Borowska
November 2009, The Journal of asthma : official journal of the Association for the Care of Asthma,
Copied contents to your clipboard!